A more appropriate negative control outcome might be another laboratory value, such as cholesterol or liver function tests, where mineralocorticoid receptor antagonists have no plausible effect, but would likely also be tested in individuals that use mineralocorticoid receptor antagonists (eg, people with heart failure). This evidence concerns the gene NR3C2 and heart failure.